These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31779300)

  • 1. Not Up for Discussion: Applying Lukes' Power Model to the Study of Health System Corruption Comment on "We Need to Talk About Corruption in Health Systems".
    Reynolds L
    Int J Health Policy Manag; 2019 Dec; 8(12):723-726. PubMed ID: 31779300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Stakes Require More Than Just Talk: What to Do About Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems".
    Vian T
    Int J Health Policy Manag; 2019 Aug; 8(8):505-507. PubMed ID: 31441292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some Things Are Rarely Discussed in Public - on the Discourse of Corruption in Healthcare Comment on "We Need to Talk About Corruption in Health Systems".
    Stiernstedt P
    Int J Health Policy Manag; 2019 Sep; 8(9):560-562. PubMed ID: 31657179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the pharmaceuticalisation of pandemic influenza using Lukes' framework of power.
    Mulinari S; Vilhelmsson A
    Sociol Health Illn; 2020 Feb; 42(2):327-341. PubMed ID: 31602672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing the Conversation, Why We Need to Reframe Corruption as a Public Health Issue Comment on "We Need to Talk About Corruption in Health Systems".
    Clarke D
    Int J Health Policy Manag; 2020 Jun; 9(6):257-259. PubMed ID: 32613794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All It Takes for Corruption in Health Systems to Triumph, Is Good People Who Do Nothing Comment on "We Need to Talk About Corruption in Health Systems".
    Mostert S; Kaspers G
    Int J Health Policy Manag; 2019 Oct; 8(10):610-612. PubMed ID: 31657188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. It Will Take a Global Movement to Curb Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems".
    Witvliet MI
    Int J Health Policy Manag; 2019 Nov; 8(11):662-664. PubMed ID: 31779291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opening the Policy Window to Mobilize Action Against Corruption in the Health Sector Comment on "We Need to Talk About Corruption in Health Systems".
    Mackey TK
    Int J Health Policy Manag; 2019 Nov; 8(11):668-671. PubMed ID: 31779293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I Know It When I See It: The Challenges of Addressing Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems".
    Kohler JC
    Int J Health Policy Manag; 2019 Sep; 8(9):563-566. PubMed ID: 31657180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why We Must Talk About Institutional Corruption to Understand Wrongdoing in the Health Sector Comment on "We Need to Talk About Corruption in Health Systems".
    Fotaki M
    Int J Health Policy Manag; 2020 May; 9(5):206-208. PubMed ID: 32563221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corruption - Taking a Deeper Dive Comment on "We Need to Talk About Corruption in Health Systems".
    Gaitonde R
    Int J Health Policy Manag; 2019 Nov; 8(11):672-674. PubMed ID: 31779294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demystify False Dilemmas to Speak About Corruption in Health Systems: Different Actors, Different Perspectives, Different Strategies Comment on "We Need to Talk About Corruption in Health Systems".
    Hussmann K
    Int J Health Policy Manag; 2019 Oct; 8(10):620-622. PubMed ID: 31657191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. We Need to Measure and Address Corruption and Poor Governance in Health Systems Comment on "We Need to Talk About Corruption in Health Systems".
    Lewis M
    Int J Health Policy Manag; 2019 Oct; 8(10):616-619. PubMed ID: 31657190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corruption in Health Systems: The Conversation Has Started, Now Time to Continue it Comment on "We Need to Talk About Corruption in Health Systems".
    Lu HS; Ho BX; Miranda JJ
    Int J Health Policy Manag; 2020 Mar; 9(3):128-132. PubMed ID: 32202098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Our Blind Spots in the Fight Against Health Systems Corruption Comment on "We Need to Talk About Corruption in Health Systems".
    Huss R
    Int J Health Policy Manag; 2020 Jan; 9(1):34-38. PubMed ID: 31902193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. We Need to Talk About Corruption in Health Systems.
    Hutchinson E; Balabanova D; McKee M
    Int J Health Policy Manag; 2019 Apr; 8(4):191-194. PubMed ID: 31050963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches.
    Vian T
    Glob Health Action; 2020; 13(sup1):1694744. PubMed ID: 32194010
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting anticorruption interventions at the front line: developmental governance in health systems.
    Hutchinson E; Naher N; Roy P; McKee M; Mayhew SH; Ahmed SM; Balabanova D
    BMJ Glob Health; 2020 Dec; 5(12):. PubMed ID: 33272939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corporate practices and health: a framework and mechanisms.
    Madureira Lima J; Galea S
    Global Health; 2018 Feb; 14(1):21. PubMed ID: 29448968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.